Skip Nav Destination

Issues

Select Year

Issue

In this Issue

High throughput technologies for marker discovery and validation
Functional and molecular imaging in vivo and in vitro
Nanotechnology approaches to molecular marker identification and validation
Molecular classification, predictive, and prognostic markers including cancer stem cells
Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization
Minimally invasive markers, circulating tumor cells, and plasma DNA and protein
Pharmacodynamics, pharmacokinetics, and pharmacogenomics
Molecular marker driven clinical trial design and implementation
Other Molecular Diagnostics Studies
Nanotechnology approaches to molecular marker identification and validation
High throughput technologies for marker discovery and validation
Nanotechnology approaches to molecular marker identification and validation
Molecular marker driven clinical trial design and implementation
Functional and molecular imaging in vivo and in vitro
Molecular classification, predictive, and prognostic markers including cancer stem cells
Pharmacodynamics, pharmacokinetics, and pharmacogenomics
Identification and validation of biomarkers
High throughput technologies for marker discovery and validation
Minimally invasive markers, circulating tumor cells, and plasma DNA and protein
Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization
High throughput technologies for marker discovery and validation
Pharmacodynamics, pharmacokinetics, and pharmacogenomics
Hurdles to molecular diagnostics development and implementation
Molecular prediction, classification, and prognostic markers
Molecular classification, predictive, and prognostic markers including cancer stem cells
Pharmacodynamics, pharmacokinetics, and pharmacogenomics
Functional and molecular imaging in vivo and in vitro
Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization
Molecular classification, predictive, and prognostic markers including cancer stem cells
Molecular marker driven clinical trial design and implementation
Molecular classification, predictive, and prognostic markers including cancer stem cells
High throughput technologies for marker discovery and validation
Other Molecular Diagnostics Studies
Molecular classification, predictive, and prognostic markers including cancer stem cells
Nanotechnology approaches to molecular marker identification and validation
Minimally invasive markers, circulating tumor cells, and plasma DNA and protein
Molecular classification, predictive, and prognostic markers including cancer stem cells
Other Molecular Diagnostics Studies
Molecular classification, predictive, and prognostic markers including cancer stem cells

Search within issue:

Search within issue

AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development– Sep 27-30, 2010; Denver, CO

High throughput technologies for marker discovery and validation

Functional and molecular imaging in vivo and in vitro

Nanotechnology approaches to molecular marker identification and validation

Molecular classification, predictive, and prognostic markers including cancer stem cells

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Molecular marker driven clinical trial design and implementation

Other Molecular Diagnostics Studies

Nanotechnology approaches to molecular marker identification and validation

High throughput technologies for marker discovery and validation

Nanotechnology approaches to molecular marker identification and validation

Molecular marker driven clinical trial design and implementation

Functional and molecular imaging in vivo and in vitro

Molecular classification, predictive, and prognostic markers including cancer stem cells

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Identification and validation of biomarkers

High throughput technologies for marker discovery and validation

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

High throughput technologies for marker discovery and validation

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Hurdles to molecular diagnostics development and implementation

Molecular prediction, classification, and prognostic markers

Molecular classification, predictive, and prognostic markers including cancer stem cells

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Functional and molecular imaging in vivo and in vitro

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

Molecular classification, predictive, and prognostic markers including cancer stem cells

Molecular marker driven clinical trial design and implementation

Molecular classification, predictive, and prognostic markers including cancer stem cells

High throughput technologies for marker discovery and validation

Other Molecular Diagnostics Studies

Molecular classification, predictive, and prognostic markers including cancer stem cells

Nanotechnology approaches to molecular marker identification and validation

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Molecular classification, predictive, and prognostic markers including cancer stem cells

Other Molecular Diagnostics Studies

Molecular classification, predictive, and prognostic markers including cancer stem cells

All Issues

Issues

AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development– Sep 27-30, 2010; Denver, CO

High throughput technologies for marker discovery and validation

Functional and molecular imaging in vivo and in vitro

Nanotechnology approaches to molecular marker identification and validation

Molecular classification, predictive, and prognostic markers including cancer stem cells

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Molecular marker driven clinical trial design and implementation

Other Molecular Diagnostics Studies

Nanotechnology approaches to molecular marker identification and validation

High throughput technologies for marker discovery and validation

Nanotechnology approaches to molecular marker identification and validation

Molecular marker driven clinical trial design and implementation

Functional and molecular imaging in vivo and in vitro

Molecular classification, predictive, and prognostic markers including cancer stem cells

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Identification and validation of biomarkers

High throughput technologies for marker discovery and validation

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

High throughput technologies for marker discovery and validation

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Hurdles to molecular diagnostics development and implementation

Molecular prediction, classification, and prognostic markers

Molecular classification, predictive, and prognostic markers including cancer stem cells

Pharmacodynamics, pharmacokinetics, and pharmacogenomics

Functional and molecular imaging in vivo and in vitro

Basic research, epigenetics, immunology, non-coding RNAs, tumor microenvironment, metastasis, target identification, validation, lead discovery, and optimization

Molecular classification, predictive, and prognostic markers including cancer stem cells

Molecular marker driven clinical trial design and implementation

Molecular classification, predictive, and prognostic markers including cancer stem cells

High throughput technologies for marker discovery and validation

Other Molecular Diagnostics Studies

Molecular classification, predictive, and prognostic markers including cancer stem cells

Nanotechnology approaches to molecular marker identification and validation

Minimally invasive markers, circulating tumor cells, and plasma DNA and protein

Molecular classification, predictive, and prognostic markers including cancer stem cells

Other Molecular Diagnostics Studies

Molecular classification, predictive, and prognostic markers including cancer stem cells

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only